Replies to post #737525 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

What do you think of Dr.Linda Liau's academic achievement?

https://scholar.google.com/citations?hl=en&user=bDpdeJIAAAAJ

[RobotDroid]

It was a good article, you just failed to point out mute inept nonmanagement's lack of communication causing the new lows in the stock. They really showed they don't care about the SH, and instead grifted themselves undeserved shares.

[learningcurve2020]

Galzus, I haven't signed up yet to read but if it addresses the One women CEO CFO COB show and her two private CMO contractor inserted into the middle of operations, I will. A bonus would be explaining what a former high ranking CIA official is doing on this tiny company's board.  Was any of that addressed? Thanks.

[froggmister]

I think your risk/reward thesis has some merit but is skewed due to some glaring omissions on the reward side. Without changing this from a top line article to deep dive, here are the most glaring omissions that impact the investment thesis:

1. The revisions Ex just outlined, as well as the failure to mention that the efficacy thesis was supported in one of the top journals in the country, JAMA, and authored by and co-signed by some the top neuro-oncologists in the world

2. Corollary to Ex's response: the results in r-GBM were omitted despite the current SOC for that indication is palliative care

3. You mention that good treatments for GBM is an unmet need but do not mention that in addition to the evidence of efficacy DCVax-L's benign side effect profile is rare and significant

4. You fail to mention that there are myriad additional data that support the long tail shown in the Ph3 trial, as well as myriad data suggesting significant opportunity when combined with other agents

5. The potential, if approved, to move towards treating other solid tumors and the potential of that development

[improving]

Whew, that was close! Thanks for signing up just today to save us all; gosh - you were almost too late!
Always enjoy hearing from someone new - on the eve of a regulatory decision- who is spreading fear, uncertainty and doubt. Likely means the shorting sponsors are uncomfortable with their present troops.

[GoodGuyBill]

[XMaster2023]

Galzus, if you’re in the Oncology world, what do you think of the Journal Article and the 73 coauthors that put their reputation on the line to endorse DCVax-L? Do you know any of them? It’s cowardly to hide behind a pseudonym if you’re going to disagree with the professionals who actually have reviewed the data. Do you have a PhD? What are your credentials?
If you’re concerned about your reputation, respond to meirluc‘s post.

[SkyLimit2022]

Galzus,

72 hours??

“Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours.”